Invasive meningococcal disease in children and adults in a tertiary level hospital. Recent epidemiology and prognostic factors

Gil-Prieto, 2011, The burden of hospitalizations for meningococcal infection in Spain (1997–2008), Vaccine, 29, 5765, 10.1016/j.vaccine.2011.05.089 Manzanares-Laya, 2018, El declive de la incidencia de enfermedad meningocócica en Barcelona entre 1988 y 2015: la influencia de la vacunación frente al serogrupo C, Med Clin (Barc), 151, 390, 10.1016/j.medcli.2018.01.015 Moreno-Pérez, 2018, Calendario de vacunaciones de la Asociación Española de Pediatría (CAV-AEP): recomendaciones 2018, An Pediatr, 88, 53, 10.1016/j.anpedi.2017.10.001 Sadarangani, 2016, Can we control all-cause meningococcal disease in Europe?, Clin Microbiol Infect, 22, S103, 10.1016/j.cmi.2016.03.006 Centers for Disease Control and Prevention (CDC), 2015 Ministerio de Sanidad, Consumo y Bienestar Social, 2014 The European Committee on Antimicrobial Susceptibility Testing – EUCAST. Available from: http://www.eucast.org/ [accessed 26.07.18]. Sadarangani, 2015, Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study, Clin Infect Dis, 60, e27, 10.1093/cid/civ028 Rivero-Calle, 2016, The burden of pediatric invasive meningococcal disease in Spain (2008–2013), Pediatr Infect Dis J, 35, 407, 10.1097/INF.0000000000001048 European Centre for Disease Prevention and Control, 2015 Campbell, 2015, Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015, Euro Surveill, 20, 10.2807/1560-7917.ES2015.20.28.21188 Bröker, 2014, Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012, Hum Vaccin Immunother, 10, 1725, 10.4161/hv.28206 Abad, 2016, Early evidence of expanding W ST-11 CC meningococcal incidence in Spain, J Infect, 73, 296, 10.1016/j.jinf.2016.06.010 Centro Nacional de Vigilancia Epidemiológica. Instituto de Salud Carlos III. Boletín Epidemiológico Semanal en Red. Enfermedad meningocócica. Semanas 41/2015 a 40/2016. Coldiron, 2016, Case-fatality rates and sequelae resulting from Neisseria meningitidis serogroup C epidemic, Niger, 2015, Emerg Infect Dis, 22, 1827, 10.3201/eid2210.160731 Heckenberg, 2008, Clinical features outcome, and meningococcal genotype in 258 adults with meningococcal meningitis, Medicine (Baltimore), 87, 185, 10.1097/MD.0b013e318180a6b4 Schildkamp, 1996, Clinical manifestations and course of meningococcal disease in 562 patients, Scand J Infect Dis, 28, 47, 10.3109/00365549609027149 Tesoro, 1991, Factors affecting outcome in meningococcal infections, Am J Dis Child, 145, 218 Algren, 1993, Predictors of outcome in acute meningococcal infection in children, Crit Care Med, 21, 447, 10.1097/00003246-199303000-00024 Stiehm, 1966, Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient, J Pediatr, 68, 457, 10.1016/S0022-3476(66)80250-0 Malley, 1996, Multivariable predictive models for adverse outcome of invasive meningococcal disease in children, J Pediatr, 129, 702, 10.1016/S0022-3476(96)70153-1 Castellanos-Ortega, 2002, A new prognostic scoring system for meningococcal septic shock in children. Comparison with three other scoring systems, Intensive Care Med, 28, 341, 10.1007/s00134-001-1196-z Barquet, 1997, Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group, JAMA, 278, 491, 10.1001/jama.1997.03550060067038 Booy, 2001, Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery, Arch Dis Child, 85, 386, 10.1136/adc.85.5.386 Thorburn, 2001, Mortality in severe meningococcal disease, Arch Dis Child, 85, 382, 10.1136/adc.85.5.382 Ninis, 2005, The role of healthcare delivery in the outcome of meningococcal disease in children: case–control study of fatal and non-fatal cases, BMJ, 330, 1475, 10.1136/bmj.330.7506.1475 Grupo de trabajo de la Guía de Práctica Clínica sobre el Manejo de la Enfermedad Meningocócica Invasiva. Guía de Práctica Clínica sobre el Manejo de la Enfermedad Meningocócica Invasiva. Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto Aragonés de Ciencias de la Salud; 2013. Guías de Práctica Clínica en el SNS: IACS N.° 2011/01. National Institute for Health and Care Excellence, 2010 Brouwer, 2015, Corticosteroids for acute bacterial meningitis, Cochrane Database Syst Rev, 10.1002/14651858.CD004405.pub5 Pollard, 2007, Emergency management of meningococcal disease: eight years on, Arch Dis Child, 92, 283, 10.1136/adc.2006.102384 Pace, 2012, Meningococcal disease: clinical presentation and sequelae, Vaccine, 30, B3, 10.1016/j.vaccine.2011.12.062 Buysse, 2009, Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock, Arch Dis Child, 94, 381, 10.1136/adc.2007.131862